Skip to content
Call us: 1.866.928.0928
  • Click here for 2022 Conference Info
Dawson James Logo
  • ABOUT US
    • BOARD OF DIRECTORS
    • MANAGEMENT
    • MANAGING PARTNERS
    • LOCATIONS
    • CAREERS
  • REG BI/CRS
  • DISCLOSURES
    • MSRB
    • IRA Contributions for 2023
  • SERVICES
    • INDIVIDUAL INVESTORS
    • INVESTMENT BANKING
    • RESEARCH
    • CAPITAL MARKETS
    • SYNDICATE
    • INSTITUTIONAL SALES & TRADING
    • INSURANCE
    • WEALTH MANAGEMENT
  • TRANSACTIONS
  • CAREERS
  • RESEARCH
  • CONFERENCES
    • 2022 CONFERENCE
    • 2021 CONFERENCE
    • 2019 CONFERENCE
    • 2018 CONFERENCE
    • 2017 CONFERENCE
    • Uplist BootCamp 2017
    • 2016 CONFERENCE
    • 2015 CONFERENCE
  • NEWS
  • CONTACT US
  • ABOUT US
    • BOARD OF DIRECTORS
    • MANAGEMENT
    • MANAGING PARTNERS
    • LOCATIONS
    • CAREERS
  • REG BI/CRS
  • DISCLOSURES
    • MSRB
    • IRA Contributions for 2023
  • SERVICES
    • INDIVIDUAL INVESTORS
    • INVESTMENT BANKING
    • RESEARCH
    • CAPITAL MARKETS
    • SYNDICATE
    • INSTITUTIONAL SALES & TRADING
    • INSURANCE
    • WEALTH MANAGEMENT
  • TRANSACTIONS
  • CAREERS
  • RESEARCH
  • CONFERENCES
    • 2022 CONFERENCE
    • 2021 CONFERENCE
    • 2019 CONFERENCE
    • 2018 CONFERENCE
    • 2017 CONFERENCE
    • Uplist BootCamp 2017
    • 2016 CONFERENCE
    • 2015 CONFERENCE
  • NEWS
  • CONTACT US
Loading...
Report – Sonoma Pharmaceuticalsnerdadmin2018-12-06T19:28:46-05:00

Sonoma Pharmaceuticals

Latest Publication

Update 12/6/18

Update 6/26/18

Update 2/22/18

Update 11/14/17

Update 08/14/17

Note 12/05/16

Suspension of Rating 08/31/16

Initiation 08/17/09

Note 01/14/16

Latest Update 12/04/15

Note 12/02/15

Note 09/24/15

Note 07/08/15

Note 06/26/15

Note 06/18/15

Note 01/07/15

Note 11/04/14

Note 10/31/14

Note 09/11/14

Note 04/10/14

Note 02/20/14

Note 01/08/14

Note 11/20/13

Note 06/07/13

Note 05/01/13

Note 03/26/13

Note 03/13/13

  • Research Philosophy
  • Reports
  • Terminated Coverage
  • Sector Research
  • Appearances
  • Webinars


“To view Dawson James’ Business Continuity Plan please click here for more information.”

Please note our Corporate address has changed as of October 12, 2020.

Dawson James Securities Inc.
Member FINRA/SIPC
101 N. Federal Highway Suite 600 Boca Raton, Florida 33432
Privacy Pledge | Contact Us | Terms & Conditions | FINRA | SIPC | FINRA BrokerCheck | Fees | Disclosures | Rule 606 Reports | Client Login
Page load link

“To view Dawson James’ Business Continuity Plan amidst the COVID-19 crisis please click here for more information.”

Go to Top